Sagent's injectable antibiotics enter market

SCHAUMBURG, Ill. Generic drug maker Sagent Pharmaceuticals has launched two injectable antibiotics, the company said Tuesday.

Sagent announced the launch of ampicillin and ampicillin with sulbactam. Ampicillin had sales of around $42 million during the 12-month period ended in June, while ampicillin with sulbactam had sales of around $40 million during the same period, according to IMS Health.

“The launch of these products increases Sagent’s anti-infectives portfolio to 11 injectable products in a variety of sizes, concentrations and packaging configurations,” Sagent CEO and board chairman Jeffrey Yordon said.